Structural basis for the biological activity of dendrotoxin-I, a potent potassium channel blocker

A topochemical model to explain the biological activity of dendrotoxin-I (DTX-I), a potent blocker for potassium channels. was developed by searching common spatial arrangements of functionally important residues between DTX-I, alpha-dendrotoxin, dendrotoxin-K, BgK, ShK, and charybdotoxin. The first three are structurally and functionally related to one another and specifically target to Kv1 type potassium channels. The last three are structurally unrelated to the first three but have the ability to displace I-125-labeled dendrotoxins on the same types of potassium channels. In order to obtain the correct electronic surface potential, thought to be crucial for the DTX-I function, we determined the three-dimensional solution structure of DTX-I by nmr spectroscopy using its correct amino acid sequence recently determined by our group. The most interesting characteristic of our model is that DTX-I has two binding sites to potassium channels: one is the cationic domain made up of Lys residues at positions 5 in the 3(10)-helix, 28 and 29 in the beta-turn, and the other is the Lys19/Tyr17/Trp37 triad located in the antiprotease dol,lain. The cationic domain and the triad are located at the opposite sides of the molecular structure and are separated hy about 25 Angstrom between Lys29 C alpha and Tyr17 C alpha. The functional triad is characterized by three distances, d(1) similar to 7.5 Angstrom (Lys19 C alpha-the center of the Tyr17 aromatic ring), d(2) similar to 8.1 Angstrom (Lys19 C alpha-the center of the 6-membered ring of the Trp37 indole group), and d(3) similar to 7.3 Angstrom (the center of the the Tyr17 aromatic ring-the center of the 6-membered ring of the Trp37 indole group). This model should aid in the pharmaceutical design of peptide and nonpeptide drugs with potassium channel blocking potencies, as well as in understanding of the physiology, pharmacology, biochemistry, and structure-function analysis of potassium channels. (C) 2000 John Wiley & Sons, Inc. Biopoly 54: 44-57, 2000.